[2/3 The antimetabolites (azathioprine and mycophenolate)].
Rave
Maryline
M
Limat
Samuel
S
Woronoff-Lemsi
Marie-Christine
MC
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018579:Patient Selection
D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine